May 1 |
Tevogen Bio Holdings Inc. reports FY results
|
May 1 |
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 11 |
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
|
Apr 8 |
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
|
Apr 3 |
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
|
Mar 28 |
Tevogen Bio reports series A-1 preferred stock investment at $10 conversion price
|
Mar 28 |
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
|
Mar 5 |
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita
|
Feb 27 |
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI
|